EWTX
Edgewise Therapeutics Inc
41.40$
+2.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1,191.4% | – | – | – | -1,272.8% | – | – | – | – | – | – | – | |
| – | 23.7% | – | – | – | 29.7% | – | – | – | – | – | – | – | |
| – | 228.8% | – | – | – | 365.3% | – | – | – | – | – | – | – | |
| – | -8.9% | – | – | – | 327.7% | – | – | – | – | – | – | – | |
| – | 7.1% | – | – | – | 12.9% | – | – | – | – | – | – | – | |
| – | 1,198.2% | – | – | – | 987.8% | – | – | – | – | – | – | – | |
| – | 2,352.9% | – | – | – | 136.7% | – | – | – | – | – | – | – | |
| – | 2,359.7% | – | – | – | -148.3% | – | – | – | – | – | – | – | |
| – | -1,198.5% | – | – | – | -1,285.7% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.